Print this page    •   Back to Web version of article

6th Conference on Retroviruses and Opportunistic Infections (CROI)
Light at the End of the Tunnel?

Conference Review
By Jeffrey T. Schouten, M.D., Brian Coppedge, HIV Treatment Specialist, and Dan Dawson

Index of Conference Summaries


Overview

Web Access to Conference Information

Access to most of the information presented at the CROI is available from the conference's own excellent web site: www.retroconference.org. Many of the lectures can be heard on that site, and the slide shows can also be viewed. All of the abstracts from the CROI are available on their web site, and can be searched as well. Additionally, for the first time ever, the CROI has published all of the posters on their web site.

Other excellent sites are the HealthCG site (now owned by Medscape) at www.healthcg.com and hiv.medscape.com/conferences/retro99/, which has extensive daily reports written by prominent HIV specialists. Another good web site with conference information in the National AIDS Treatment Advocacy Project, at www.natap.org.

More than 3,500 people gathered in Chicago from January 31 through February 4, 1999, for the 6th Conference on Retroviruses and Opportunistic Infections (CROI). This conference began in 1994 as a small meeting for basic scientists studying the HIV virus and clinicians treating people with HIV. It is now one of the most important annual HIV gatherings, attracting virologists, immunologists, HIV community treatment activists, community press, and clinicians treating people with HIV.

The general media gave the greatest coverage to the presentation that convincingly demonstrated that HIV originated in monkeys and has been transferred to humans at least three times. However, the most clinically relevant and important presentations at the 6th CROI were those that hinted that HIV might be controlled with a combination of highly active antiretroviral therapy (HAART) and stimulation of the immune response to fight HIV. There is very real hope that someday, after suppression of viral replication and boosting of the immune system's response to HIV, patients will be able to stop HAART. Eradication might not be necessary -- only containment of the virus, as occurs with herpes, cytomegalovirus (CMV), and several other viral infections.

Information about a number of intriguing issues was also presented at the 6th CROI:


Index of STEP Conference Summaries

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.




This article was provided by Seattle Treatment Education Project. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art1922.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.